Revlimid : Orphan designation withdrawal assessment report (post-authorisation)
Pharmazeutisch
Revlimid : Orphan designation withdrawal assessment report (post-authorisation)
Fortschrittliche pharmazeutische Formulierung für gezielte therapeutische Intervention.
Dosierung
Revlimid : Orphan designation withdrawal assessment report (post-authorisation)
Stärke
Revlimid : Orphan designation withdrawal assessment report (post-authorisation)
Packungsgröße
Revlimid : Orphan designation withdrawal assessment report (post-authorisation)
Form
Revlimid : Orphan designation withdrawal assessment report (post-authorisation)
Quelle
European Medicines Agency
Sicherheitsprofil
Kontraindikationen
Revlimid : Orphan designation withdrawal assessment report (post-authorisation)
Nebenwirkungen
Revlimid : Orphan designation withdrawal assessment report (post-authorisation)
Scanne diesen QR-Code, um schnell auf diese Seite auf deinem Mobilgerät zuzugreifen.